1. Korea Forest Research Institute. National Academy of Agricultural Science. Poisonous mushroom in the woods. Seoul: Korea Forest Research Institute; 2014.
2. Seok SJ, Kim YS, Kim WG, Suh JS, Jeong MH, Lim KS, Sohn CH, Lee YS. Encyclopedia of poisonous mushrooms. Seoul: Blue Happiness Press; 2011.
3. Auerbach PS. Wilderness medicine. 6th ed. Edinburgh: Mosby; 2011.
5. Busi C, Fiume L, Costantino D, Langer M, Vesconi F. Amanita toxins in gastroduodenal fluid of patients poisoned by the mushroom, Amanita phalloides. N Engl J Med 1979;300:800.
6. Garrouste C, Hemery M, Boudat AM, Kamar N. Amanita phalloides poisoning-induced end-stage renal failure. Clin Nephrol 2009;71:571-574.
7. Kelner MJ, Alexander NM. Endocrine hormone abnormalities in Amanita poisoning. J Toxicol Clin Toxicol 1987;25:21-37.
9. Floersheim GL, Weber O, Tschumi P, Ulbrich M. Clinical death-cap (Amanita phalloides) poisoning: prognostic factors and therapeutic measures: analysis of 205 cases. Schweiz Med Wochenschr 1982;112:1164-1177.
11. Hoffman RS, Howland MA, Lewin NA, Nelson L, Goldfrank LR. Goldfrank's toxicologic emergencies. 10th ed. New York: McGraw-Hill Education; 2015.
12. Piqueras J, Duran-Suarez JR, Massuet L, Hernandez-Sanchez JM. Mushroom poisoning: therapeutic apheresis or forced diuresis. Transfusion 1987;27:116-117.
13. Enjalbert F, Rapior S, Nouguier-Soule J, Guillon S, Amouroux N, Cabot C. Treatment of amatoxin poisoning: 20-year retrospective analysis. J Toxicol Clin Toxicol 2002;40:715-757.
14. Erffmeyer JE. Adverse reactions to penicillin. Part I. Ann Allergy 1981;47:288-293.
15. Neftel KA, Hauser SP, Muller MR. Inhibition of granulopoiesis in vivo and in vitro by beta-lactam antibiotics. J Infect Dis 1985;152:90-98.
16. Laekeman G, De Coster S, De Meyer K. St. Mary's Thistle: an overview. J Pharm Belg 2003;58:28-31.
17. Ramellini G, Meldolesi J. Liver protection by silymarin: in vitro effect ondissociated rat hepatocytes. Arzneimittelforschung 1976;26:69-73.
18. Vogel G, Trost W, Braatz R, Odenthal KP, Brusewitz G. Studies on pharmacodynamics, site and mechanism of action of silymarin, the anti-hepatotoxic principle from Silybum marianum (L.). Arzneimittelforschung 1975;25:179-188.
19. Flora K, Hahn M, Rosen H, Benner K. Milk thistle (Silybum marianum) for the therapy of liver disease. Am J Gastroenterol 1998;93:139-143.
20. Wellington K, Jarvis B. Silymarin: a review of its clinical properties in the management of hepatic disorders. BioDrugs 2001;15:465-489.
21. Floersheim GL. Treatment of mushroom poisoning. JAMA 1985;253:3252.
22. Schneider SM, Borochovitz D, Krenzelok EP. Cimetidine protection against alpha-amanitin hepatotoxicity in mice: a potential model for the treatment of Amanita phalloides poisoning. Ann Emerg Med 1987;16:1136-1140.
23. Vanscoy GJ, Schneider SM. Cimetidine and ascorbic-acid in the treatment of alpha-amanitin toxicity in mice. Vet Hum Toxicol 1988;30:368.
24. Azar A, Thomas AA, Shillito FH. Pyridoxine and phenobarbital as treatment for aerozine-50 toxicity. Aerosp Med 1970;41:1-4.
25. Klosterman HJ. Vitamin B6 antagonists of natural origin. J Agric Food Chem 1974;22:13-16.
26. Lincoff G, Mitchel DH, Liberman IE. Toxic and hallucinogenic mushroom poisoning: a handbook for physicians and mushroom hunters. New York: Van Nostrand Reinhold; 1977.
27. Honegger P, Pardo B, Monnet-Tschudi F. Muscimol-induced death of GABAergic neurons in rat brain aggregating cell cultures. Brain Res Dev Brain Res 1998;105:219-225.
28. Gilad E, Biger Y. Paralysis of convergence caused by mushroom poisoning. Am J Ophthalmol 1986;102:124-125.
29. Mendelson G. Treatment of hallucinogenic-plant toxicity. Ann Intern Med 1976;85:126.
30. Satora L, Pach D, Ciszowski K, Winnik L. Panther cap Amanita pantherina poisoning case report and review. Toxicon 2006;47:605-607.
33. Mccawley EL, Brummett RE, Dana GW. Convulsions from psilocybe mushroom poisoning. Proc West Pharmacol Soc 1962;5:27-33.